Search

Now showing items 1-4 of 4

Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.

SMYTH, PAUL; MARTIN, CARA; MCINERNEY, JAMIE KEVIN; ELBARUNI, SALAH AMRU; O'LEARY, JOHN; SALLEY, YVONNE; VENCKEN, SEBASTIAN; O'TOOLE, SHARON; AHERNE, SINEAD; SHEILS, ORLA; GALLAGHER, MICHAEL (2009)

Correlation of p16(INK4A) expression and HPV copy number with cellular FTIR spectroscopic signatures of cervical cancer cells.

MARTIN, CARA; O'LEARY, JOHN (2011)

Evaluation of the clinical performance of the cobas 4800 HPV test in patients referred for colposcopy.

O'TOOLE, SHARON; PILKINGTON, LORETTO; MARTIN, CARA; O'LEARY, JOHN; KEEGAN, HELEN (2013)

The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.

MARTIN, CARA; SHEILS, ORLA; SMYTH, PAUL; FINN, STEPHEN; O'LEARY, JOHN; GALLAGHER, MICHAEL; BATES, MARK; SPILLANE, CATHY (2014)

Browse

All of TARA

This Academic/Research Unit

Discover

Author

Subject

Date Issued

Sponsor

Search

Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.

Correlation of p16(INK4A) expression and HPV copy number with cellular FTIR spectroscopic signatures of cervical cancer cells.

Evaluation of the clinical performance of the cobas 4800 HPV test in patients referred for colposcopy.

The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.

Browse

All of TARA

This Academic/Research Unit

Discover

Author

Subject

Date Issued

Sponsor

Search

Advanced Search

Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.

Correlation of p16(INK4A) expression and HPV copy number with cellular FTIR spectroscopic signatures of cervical cancer cells.

Evaluation of the clinical performance of the cobas 4800 HPV test in patients referred for colposcopy.

The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.